• Home
  •  / iSTAR Medical

iSTAR Medical

OverviewSuggest Edit

iSTAR Medical develops ophthalmic implants from biomaterials. The Company is focused on the development of novel ophthalmic implants for patients with glaucoma.

TypePrivate
Founded2009
HQWavre, BEMap
Websiteistarmed.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2021)25(+5%)
Cybersecurity ratingAMore

Key People/Management at iSTAR Medical

Michel Vanbrabant

Michel Vanbrabant

CEO and Director
Michel Lussier

Michel Lussier

Chairman
Dan Scherrer

Dan Scherrer

VP Operations
Zubair Hussain

Zubair Hussain

VP Regulatory & Clinical Affairs
Marc Nolet de Brauwere

Marc Nolet de Brauwere

Director
Nadia Verwilghen

Nadia Verwilghen

VP Finance
Show more

iSTAR Medical Office Locations

iSTAR Medical has an office in Wavre
Wavre, BE (HQ)
6 Avenue Sabin
Show all (1)

iSTAR Medical Financials and Metrics

Summary Metrics

Founding Date

2009

iSTAR Medical total Funding

$61.2 m

iSTAR Medical latest funding size

$44.14 m

Time since last funding

2 years ago

iSTAR Medical investors

Gimv, S.R.I.W., Capricorn Venture Partners, Société Régionale d'Investissement de Wallonie, Capricorn Health-Tech Fund, Namur Invest, LSP, SFPI-FPIM, Earlybird, BNP Paribas Fortis Private Equity, Capricorn Partners, Walloon Region Investment Fund, Belgian Federal Investment Fund
iSTAR Medical's latest funding round in September 2019 was reported to be $44.1 m. In total, iSTAR Medical has raised $61.2 m
Show all financial metrics

iSTAR Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

Learn more about our premium products
SecurityScorecard logo

iSTAR Medical Online and Social Media Presence

iSTAR Medical's Trends

Embed Graph

iSTAR Medical News and Updates

September 05, 2019

iSTAR Medical grabs Series C

Belgium-based iSTAR Medical SA, a developer of ophthalmic implants for the treatment of glaucoma, has raised 40 million euros in Series C financing. LSP and Gimv led the round with participation from Earlybird, BNP Paribas Fortis Private Equity, Capricorn Partners, Walloon Region Investment Fund and…
September 05, 2019

iSTAR Medical Announces EUR 40m Series C Financing

WAVRE, Belgium, Sept. 5, 2019 /PRNewswire/ -- iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C financing. The financing was led by healthcare specialist funds LSP and...

iSTAR Medical Blogs

March 02, 2021

MINIject STAR-II 12-month trial results at AGS

The 12-month results from the European STAR-II trial of iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM will be presented at the American Glaucoma Society (AGS) meeting. Data from the trial confirm that MINIject is a powerful treatment option to significantly reduce intr…
February 04, 2021

MINIject in Ophthalmology Times Europe

An article in Ophthalmology Times Europe outlines how the suprachoroidal space promises to become a feasible route to effectively reduce intraocular pressure (IOP) in patients with glaucoma, thanks to iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM. According to Professo…
January 20, 2021

MINIject in Glaucoma Physician journal

In the latest issue of Glaucoma Physician, iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM features as a prominent solution to unlock the potential of the suprachoroidal space in glaucoma treatment. In his “Suprachoroidal Devices in Glaucoma Therapy” article, glaucoma an…
November 16, 2020

iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

Growing body of evidence confirms MINIject is safe and effective with results sustained over time WAVRE, Belgium — 16 November 2020: iSTAR Medical, a medtech company developing minimally invasive ophthalmic implants for treatment of patients with glaucoma, today announced positive one-year results f…
November 03, 2020

iSTAR Medical’s “emerging technology” presented at IGC

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, has been presented as part of the ‘Emerging Technologies’ session at the prestigious 2020 virtual Interventional Glaucoma Congress (IGC) meeting. Dr Paul Singh, who presented iSTAR Medical’s technology, is a glaucoma spec…
October 29, 2020

iSTAR Medical wins BVA Award 2020!

iSTAR Medical has been awarded the 2020 BVA Venture Company of the Year at the BVA Award virtual ceremony today. The BVA Award is organised by the Belgian Venture Capital & Private Equity Association to reward and celebrate high-performing Belgian companies backed by private equity or venture ca…
Show more

 iSTAR Medical Frequently Asked Questions

  • When was iSTAR Medical founded?

    iSTAR Medical was founded in 2009.

  • Who are iSTAR Medical key executives?

    iSTAR Medical's key executives are Michel Vanbrabant, Michel Lussier and Dan Scherrer.

  • How many employees does iSTAR Medical have?

    iSTAR Medical has 25 employees.

  • Who are iSTAR Medical competitors?

    Competitors of iSTAR Medical include Cerevast Therapeutics, Impel NeuroPharma and Zipline Medical.

  • Where is iSTAR Medical headquarters?

    iSTAR Medical headquarters is located at 6 Avenue Sabin, Wavre.

  • Where are iSTAR Medical offices?

    iSTAR Medical has an office in Wavre.

  • How many offices does iSTAR Medical have?

    iSTAR Medical has 1 office.